(Q34502708)

2 August 2017

1 reference

title

Novel approaches to the treatment of thrombosis (English)

1 reference

2 August 2017

0 references

Paolo Gresele

1

1 reference

2 August 2017

Giancarlo Agnelli

series ordinal

2

1 reference

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Trends in Pharmacological Sciences

2 August 2017

published in

1 reference

2 August 2017

volume

23

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

25-32

1 reference

Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Distinct Contributions of Glycoprotein VI and α2β1 Integrin to the Induction of Platelet Protein Tyrosine Phosphorylation and Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

A revised model of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Anti-human von willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Structural basis of collagen recognition by integrin alpha2beta1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

How the protease thrombin talks to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

YD-3, a novel inhibitor of protease-induced platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Antithrombotic and vasorelaxant properties of a novel synthetic RGD peptide containing nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Design and synthesis of potent and highly selective thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901885-X

7 January 2021

10.1016/S0165-6147(00)01885-X

Identifiers

DOI

1 reference

2 August 2017

1 reference